Alistair Burns

14PUBLICATIONS
102CO-AUTHORS
Medical devicesForensic evaluation, inference and statisticsPharmacogenomicsToxicology (incl. clinical toxicology)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 13, 2025
Lecanemab appropriate use recommendations for clinical practice in the UK.

Catherine J Mummery, Jill Rasmussen, Dan Blackburn

|Jan 20, 2025
Cognitive testing and the hazards of cut-offs.

Hugh Series, Alistair Burns

|Oct 03, 2024
Understanding the medication regimens associated with anticholinergic burden in older people's mental health services in the UK.

Thomas R E Barnes, Delia Bishara, Alistair Burns

|Nov 06, 2023
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.

Sube Banerjee, Nicolas Farina, Catherine Henderson

|Jul 24, 2023
Has COVID-19 affected dementia diagnosis rates in England?

Jemma Hazan, Kathy Y Liu, Jeremy D Isaacs

|May 27, 2021
Dementia wellbeing and COVID-19: Review and expert consensus on current research and knowledge gaps.

Kathy Y Liu, Robert Howard, Sube Banerjee

Pageof 3

Frequent Collaborators

3 joint publications

Iracema Leroi

3 joint publications

Martin Knapp

3 joint publications

Catherine Henderson

2 joint publications

Chris Fox